Author： Phuphanich Surasak Supko Jeffrey Carson Kathryn Grossman Stuart Burt Nabors L. Mikkelsen Tom Lesser Glenn Rosenfeld Steve Desideri Serena Olson Jeffrey
Publisher： Springer Publishing Company
ISSN： 0167-594X
Source： Journal of Neuro-Oncology, Vol.100, Iss.1, 2010-10, pp. : 95-103
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Prados Michael Yung W. Wen Patrick Junck Larry Cloughesy Timothy Fink Karen Chang Susan Robins H. Dancey Janet Kuhn John
Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. :
Access to resources
Recommend
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
By Fabi Alessandra Metro Giulio Vidiri Antonello Lanzetta Gaetano Carosi Mariantonia Telera Stefano Maschio Marta Russillo Michelangelo Sperduti Isabella Carapella Carmine Cognetti Francesco Pace Andrea
Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. :
Phase II trial of temozolomide in children with recurrent high-grade glioma
By Ruggiero A. Cefalo G. Garré M.L. Massimino M. Colosimo C. Attinà G. Lazzareschi I. Maurizi P. Ridola V. Mazzarella G. Caldarelli M. Rocco C. Madon E. Abate M.E. Clerico A. Sandri A. Riccardi R.
Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. :
Carboplatin and bevacizumab for recurrent malignant glioma
Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. :
By Tang P. Roldan G. Brasher P.M.A Fulton D. Roa W. Murtha A. Cairncross J.G. Forsyth P.A.
Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. :